Phone screening tool for newborn jaundice after birth
Part of Genetic & congenital clinical trials.
This trial tests whether a smartphone tool can help screen newborn jaundice (yellow skin) using skin measurements. It may help doctors identify jaundice sooner and decide if a blood test is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born after 35 weeks of pregnancy
- Your baby weighs at least 1,800 grams at birth
- Your baby is between 1 and 14 days old
- A blood test for bilirubin (a jaundice-related blood measure) is needed as part of usual care
- Your baby has not had light therapy (phototherapy) in the last 24 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone app that checks for jaundice in newborns. The goal is to see if the app works well for on-the-spot screening, which could help parents and doctors detect jaundice early.
This trial tests if a skin light meter can accurately measure jaundice (bilirubin) in newborns with different skin tones. It may help reduce the need for blood tests.
This study tests a simple color scale families can use at home to check their baby's skin for jaundice (yellowing of the skin) in the first weeks after birth. It may help decide when to go to the hospital for treatment and also looks at how well breastfeeding is going.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This study tests a device that measures jaundice (yellowing of the skin) through the skin rather than with a blood test. It may help newborns avoid a needle stick.
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
Hear when a new Neonatal Jaundice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.